SCHEMBL5952624

SCHEMBL5952624

CC(C)C(C)(C)OB(O)Cc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 3/20 0.39
TSHR P16473 1/20 0.35
CYP2C19 P33261 1/20 0.34
HIF1A Q16665 1/20 0.34
LIPE Q05469 1/20 0.34
SLC6A2 P23975 3/20 0.33
TAAR1 Q96RJ0 3/20 0.33
RIPK1 Q13546 2/20 0.33
MAOA P21397 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
CYP2A6 P11509 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
MAPT P10636 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL670441 0.77 LIPE (0.35) TRPA1TSHRCYP2C19HIF1ALIPE
SCHEMBL5952636 0.73 TRPV6 (0.38) TRPA1TSHRCYP2C19HIF1ARIPK1
SCHEMBL3900187 0.71 CA1 (0.41) TSHRLIPECA1CA2MAPT
SCHEMBL23535576 0.68 LIPE (0.39) TSHRLIPECA1CA2MAPT
SCHEMBL24434854 0.68 TSHR (0.44) TRPA1TSHRSLC6A2TAAR1RIPK1
SCHEMBL3796769 0.68 CTRB1 (0.47) TSHRCYP2C19CA1CA2MAPT
SCHEMBL25377641 0.67 CA1 (0.46) TRPA1TSHRCYP2C19HIF1ALIPE
SCHEMBL1356582 0.67 CA1 (0.41) TRPA1TSHRHIF1ALIPECA1
SCHEMBL5951160 0.67 CYP1A2 (0.33) TSHRMAPTL3MBTL1MEN1ALDH1A1
SCHEMBL3887273 0.66 TSHR (0.46) TSHRCYP2C19HIF1ALIPESLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7038070-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2006-05-02 US disclosed
US-6963017-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2005-11-08 US disclosed
EP-0968158-B1 METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM BASELL POLYOLEFINE GMBH (DE) 2005-08-10 EP disclosed
US-20050033076-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2005-02-10 US disclosed
US-20030009046-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2003-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050033076-A1 Preparation of preparing substituted indanones CYP1A2, CYP2J2, IDH3A TRPA1 3969/4885TSHR 4624/4885CYP2C19 60/4885
US-20030009046-A1 Preparation of preparing substituted indanones CYP1A2, CYP1B1, CYP1A1 TRPA1 3711/4885TSHR 4667/4885CYP2C19 75/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.